”first occurrence of a non-sustained [at least 6 sec] or sustained ventricular tachycardia or ventricular fibrillation”

University of Michigan - Ann Arbor

Hazard ratios for ventricular arrhythmia among COVID-19 patients given different antimalarial and macrolide therapies  from multinational registry of patients hospitalized between 12/20/19 and 4/14/20

Mehra, M., Desai, S., Ruschitzka, F., & Patel, A. (2020). Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet. doi: 10.1016/s0140-6736(20)31180-6

Learn Before

Related